" class="no-js "lang="en-US"> Respiratory Archives - Page 2 of 2 - Medtech Alert
Friday, March 31, 2023

Sort by:


Top Post

Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV […]

NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma

Three new studies show how home monitoring technology – developed by leading digital health company NuvoAir – […]

Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market

A vaccination refers to a biological product that is utilized to provide acquired immunity against a […]

Tezepelumab Regulatory Submission Accepted and Granted FDA Priority Review in the US for the Treatment of Patients with Asthma

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for […]

NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions

NuvoAir – the digital health company on a mission to improve the lives of millions […]

Hephaï Files Software Patent for its Digital Education Platform Designed to Improve Patient Inhaler Use

Hephaï, a French start-up developing an AI-based digital education platform, today announces that it has […]

Amgen Tezepelumab BLA Submitted to U.S. FDA

Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to […]

Research Presented at RDD 2021 Suggests That Acoustic Technology Is a Viable Alternative to High-cost Electronic Smart Inhalers

Research presented at the Respiratory Drug Delivery (RDD) 2021 conference suggests that inhalers using acoustic […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more